These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18043689)

  • 1. Methadone-induced QTc prolongation: is it due to stereoselective block of hERG or to inappropriate QT interval correction?
    Andrássy G; Szabo A
    Clin Pharmacol Ther; 2008 May; 83(5):671; author reply 672. PubMed ID: 18043689
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.
    Eap CB; Crettol S; Rougier JS; Schläpfer J; Sintra Grilo L; Déglon JJ; Besson J; Croquette-Krokar M; Carrupt PA; Abriel H
    Clin Pharmacol Ther; 2007 May; 81(5):719-28. PubMed ID: 17329992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
    Fanoe S; Jensen GB; Sjøgren P; Korsgaard MP; Grunnet M
    Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs.
    Katchman AN; Koerner J; Tosaka T; Woosley RL; Ebert SN
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1098-106. PubMed ID: 16278312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.
    Johannesen L; Vicente J; Mason JW; Sanabria C; Waite-Labott K; Hong M; Guo P; Lin J; Sørensen JS; Galeotti L; Florian J; Ugander M; Stockbridge N; Strauss DG
    Clin Pharmacol Ther; 2014 Nov; 96(5):549-58. PubMed ID: 25054430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chiral isolates of methadone on the cardiac potassium channel IKr.
    Lin C; Somberg T; Molnar J; Somberg J
    Cardiology; 2009; 113(1):59-65. PubMed ID: 18984955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug-induced QT interval prolongation in telemetered common marmosets.
    Tabo M; Hara T; Sone S; Shishido N; Kuramoto S; Nakano K; Onodera H; Kimura K; Kobayashi K
    J Toxicol Sci; 2008 Aug; 33(3):315-25. PubMed ID: 18670163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data.
    Jonker DM; Kenna LA; Leishman D; Wallis R; Milligan PA; Jonsson EN
    Clin Pharmacol Ther; 2005 Jun; 77(6):572-82. PubMed ID: 15961988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of hERG potassium channel blockade by antipsychotics.
    Silvestre JS; Prous JR
    Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):457-65. PubMed ID: 17982510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
    Luo T; Luo A; Liu M; Liu X
    Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.
    Katchman AN; McGroary KA; Kilborn MJ; Kornick CA; Manfredi PL; Woosley RL; Ebert SN
    J Pharmacol Exp Ther; 2002 Nov; 303(2):688-94. PubMed ID: 12388652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-quality triplicate electrocardiogram monitoring in a first-in-man study: potential for early detection of drug-induced QT prolongation.
    He YL; Zhang Y; Yan JH; Zhou W; Komjathy S; Taylor A
    Int J Clin Pharmacol Ther; 2013 Dec; 51(12):948-57. PubMed ID: 24120715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking for virtuous promiscuity: electrocardiographic evidence of multichannel drug block.
    Haigney MC
    Clin Pharmacol Ther; 2014 Nov; 96(5):534-6. PubMed ID: 25336265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of probucol, a typical hERG expression inhibitor, on in vivo QT interval prolongation in conscious dogs.
    Nogawa H; Kawai T; Yajima M; Miura M; Ogawa T; Murakami K
    Eur J Pharmacol; 2013 Nov; 720(1-3):29-37. PubMed ID: 24211675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypaconitine-induced QT prolongation mediated through inhibition of KCNH2 (hERG) potassium channels in conscious dogs.
    Xie S; Jia Y; Liu A; Dai R; Huang L
    J Ethnopharmacol; 2015 May; 166():375-9. PubMed ID: 25800797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hERG potassium channels and cardiac arrhythmia.
    Sanguinetti MC; Tristani-Firouzi M
    Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG.
    Mittelstadt SW; Hemenway CL; Craig MP; Hove JR
    J Pharmacol Toxicol Methods; 2008; 57(2):100-5. PubMed ID: 18291682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.